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Abstract: The immunotoxic potential of domoic acid (DA), a well-characterized 
neurotoxin, has not been fully investigated. Phagocytosis and lymphocyte proliferation 
were evaluated following in vitro and in vivo exposure to assay direct vs indirect effects. 
Mice were injected intraperitoneally with a single dose of DA (2.5 µg/g b.w.) and sampled 
after 12, 24, or 48 hr.  In a separate experiment, leukocytes and splenocytes were exposed 
in vitro to 0, 1, 10, or 100 µM DA. In vivo exposure resulted in a significant increase in 
monocyte phagocytosis (12-hr), a significant decrease in neutrophil phagocytosis (24-hr), a 
significant decrease in monocyte phagocytosis (48-hr), and a significant reduction in T-cell 
mitogen-induced lymphocyte proliferation (24-hr).  In vitro exposure significantly reduced 
neutrophil and monocyte phagocytosis at 1 µM. B- and T-cell mitogen-induced 
lymphocyte proliferation were both significantly increased at 1 and 10 µM, and 
significantly decreased at 100 µM.  Differences between in vitro and in vivo results suggest 
that DA may exert its immunotoxic effects both directly and indirectly. Modulation of 
cytosolic calcium suggests that DA exerts its effects through ionotropic glutamate subtype 
surface receptors at least on monocytes. This study is the first to identify DA as an 
immunotoxic chemical in a mammalian species. 
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1. Introduction  
Certain species of the marine diatom Pseudo-nitzschia produce the neurotoxin domoic acid (DA), 
which fish and shellfish can concentrate, putting consumers of these species such as marine mammals 
and humans at risk for adverse effects during and subsequent to harmful algal bloom (HAB) or ‘red 
tide’ events. Over the last several decades, the frequency and global distribution of HAB incidents 
appear to have increased and may be related to human activity, such as increased pollution runoff into 
aquatic ecosystems or global warming [1]. HAB toxins, including brevetoxin, microcystin, and 
saxitoxin, are immunotoxic in humans, mice, and aquatic mammals [2-5].  DA is immunotoxic in 
oysters and mussels [6, 7].  However, the potential immunotoxicity of DA in mammals has not been 
investigated.  As human and wildlife exposure to DA is expected to continue, a better understanding of 
the sub-lethal effects of DA, as well as other HAB toxins, is warranted. 
In humans, DA is the causative agent of amnesic shellfish poisoning (ASP) with symptoms 
including nausea, vomiting, diarrhea, dizziness, seizures and permanent loss of short term memory [8]. 
In 1987, over 100 people became ill and 4 people died after eating DA-contaminated mussels 
originating from Prince Edward Island [9].  Since 1998, hundreds of California sea lion deaths were 
linked to exposure to DA, resulting from the trophic transfer of DA from diatoms to prey such as 
northern anchovy during DA HAB events [10-12]. The rate of re-stranding following treatment for DA 
exposure was approximately 20 times higher than for animals stranded for other reasons, suggesting 
chronic changes may have affected their survival [12]. Sub-clinical DA-induced immunomodulation 
may have predisposed those animals to such chronic manifestations. 
DA is a rigid analog of the neurotransmitter glutamate and a potent agonist of kainate and alpha 
amino-5-methyl-3-hydroxyisoxazolone-4-propionate (AMPA) subtypes of the glutamate receptor [13].  
Persistent activation of these receptor subtypes results in rapid excitotoxicity, with the secondary 
activation of N-methyl-D-aspartate (NMDA) glutamate receptors and voltage dependent calcium 
channels, which leads to calcium dependent cell death and neuronal lesions in areas of the brain where 
glutamatergic pathways are heavily concentrated [14, 15].  
Recent evidence emerged that glutamatergic pathways also exist in non-neuronal tissues [15-20].  
For immune cells, NMDA receptors were identified in rat macrophages [21], while both NMDA and 
kainate/AMPA subtypes were detected in human and rodent lymphocytes [22-25] and were suggested 
to play a role in cell signaling and functional events, such as cell division.   
The weight of evidence suggest that DA may be immunotoxic in mammals, as (1) DA was shown to 
be immunotoxic in bivalves [6, 7], (2) glutamate receptors (similar to receptors implicated in 
mediating neurotoxic effects) were demonstrated on mouse and human immune cells [22-25], and (3) 
exposure to glutamate modulated human mitogen-induced lymphocyte proliferation [24]. The 
hypothesis for the present study is that DA is immunotoxic in a mammalian species following both in 
vitro and in vivo exposure as measured by changes in immune cell functions. In vitro studies were 
performed to determine the direct effects, i.e. without the potential influence of administration, 
distribution, metabolism or excretion (ADME), of DA on immune cells and their functions by co-
incubating isolated immune cells with DA.  In vivo studies were performed to determine the potential 
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indirect effects of DA on immune cells and their functions, i.e. with the potential influence of ADME 
and/or complex system interactions, for example, between the nervous and immune systems.  
Assays to measure immunotoxicity included peripheral blood leukocyte phagocytosis and mitogen-
stimulated lymphocyte (splenocyte) proliferation upon DA exposure. Both functional immune assays 
were validated by and are part of the National Toxicology Program to predict the immunotoxicity of 
chemicals [26, 27]. Phagocytosis is a key innate immune function performed predominately by 
peripheral blood neutrophils and monocytes, providing the first line of defense against invading 
organisms, particularly bacteria. Lymphocyte proliferation is a key adaptive immune response in 
which lymphocytes proliferate upon stimulation by an antigen or mitogen and represents the first step 
towards the production of effector and memory B and T lymphocytes. 
DA has not been reported to bind directly to immune cells, however, as DA is an analog of 
glutamate, it is possible that it binds to immune cell glutamate receptor(s) in order to mediate immune 
functions. Modulation of cytosolic calcium is a mechanism involved in DA-induced neurotoxicity and 
involves cell membrane ionotropic glutamate receptors, such as AMPA and kainate receptors [15, 20].  
In an initial attempt to identify the most likely cell surface glutamate receptor(s) by which DA 
modulates immune functions, qualitative changes in cytosolic calcium mobilization induced by several 
ionotropic glutamate receptor agonists were compared to that of DA. This study provides the 
foundation to determine the immunotoxicity of DA (the hazard identification step in risk assessment) 
and elucidate the mechanisms and pathways involved in the response to toxic levels of DA in 
mammals, which may be relevant to marine mammals and humans with documented DA exposure.   
2. Results  
2.1 Leukocyte flow cytometry profile 
A representative scatterplot of the flow cytometric profile of mouse peripheral blood leukocytes is 
shown in Figure 1. The different sub-populations of cells were easily distinguished on the basis of 
relative cell size (forward scatter) and complexity (side scatter). Neutrophils were large and complex 
(granular), lymphocytes were small and less complex, and monocytes were slightly larger than 
lymphocytes and less complex than neutrophils. 
2.2 In vivo clinical signs 
The in vivo study used a single i.p. injection of dose DA, 2.5 µg/g, previously shown in mice to be 
symptomatic but sub-lethal. In this study, two of the 30 mice exposed to DA showed minimal loss of 
balance for approximately 15 sec. Within 30 min after dosing, their behavior returned to normal. No 
other clinical signs were detected within the first hour following exposure and all mice appeared 
normal prior to euthanasia at all time points.  
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Figure 1.  Flow cytometric dot plot of mouse peripheral blood leukocytes. Sub-
populations of leukocytes can be easily distinguished based on forward scatter (relative 
size) and side scatter (relative complexity). Neutrophils (R1) are large and complex; 
lymphocytes (R3) are smaller and less complex, while monocytes (R2) are slightly larger 
than lymphocytes and less complex than neutrophils. 
 
2.3 In vivo phagocytosis  
Monocyte phagocytosis measured 12 hr after exposure was significantly increased in DA-exposed 
mice compared to control mice by 29, 38, and 77% for 1+, 2+, and 3+ beads, respectively (Figure 2). 
There were no effects on neutrophil phagocytosis at that time point. Neutrophil phagocytosis measured 
24 hr after exposure was significantly decreased in DA-exposed mice compared to control mice by 14 
and 21% for 2+ and 3+ beads, respectively (Figure 3). There were no effects on monocyte 
phagocytosis at that time point. Monocyte phagocytosis measured 48 hr after exposure was 
significantly decreased in DA-exposed mice compared to control mice by 20% for 3+ beads (Figure 4). 
There were no effects on neutrophil phagocytosis at that time point.  
2.4 In vivo lymphocyte proliferation 
Twenty-four hr after exposure, T cell proliferation (with optimal ConA) was significantly reduced 
(33%) compared to control mice (Figure 5). Mitogen-induced lymphocyte proliferation was not 
significantly affected after 12 and 48 hr exposure to DA (data not shown). 
2.5 In vitro phagocytosis 
Exposure to 1µM DA significantly decreased neutrophil and monocyte phagocytosis (1+ beads 
only) by 9 and 13%, respectively, and neutrophils phagocytosis (2+ beads only) by 13 % (Figure 6). 
No effects were observed at the higher concentrations.  
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Figure 2. In vivo peripheral blood neutrophil (top) and monocyte (bottom) phagocytosis 
(mean +SD) in unexposed (control; n=10) and DA-exposed mice (n=10) 12 hr after 
exposure (t-test: *, p < 0.05). 
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Figure 3.  In vivo peripheral blood neutrophil (top) and monocyte (bottom) phagocytosis 
(mean +SD) in unexposed (control; n=10) and DA-exposed mice (n=10) 24 hr after 
exposure (t-test: *, p < 0.05). 
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Figure 4.  In vivo peripheral blood neutrophil (top) and monocyte (bottom) phagocytosis 
(mean +SD) in unexposed (control; n=10) and DA-exposed mice (n=10) 48 hr after 
exposure (t-test: *, p < 0.05). 
 
0
10
20
30
40
50
60
70
80
1+ beads 2+ beads 3+ beads
%
 N
eu
tro
ph
ils
Control
DA
0
2
4
6
8
10
12
14
16
1+ beads 2+ beads 3+ beads
%
 M
on
oc
yt
es
Control
DA
*
 
 
 
 
Mar. Drugs 2008, 6                                        
 
 
643
Figure 5. In vivo mitogen-induced lymphocyte (splenocyte) proliferation (mean +SD) in 
unexposed (control; n=10) and DA-exposed mice (n=10) 24 hr after exposure (t-test, *p < 
0.05). 
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2.6 In vitro lymphocyte proliferation 
 
Exposure to 1 µM DA significantly increased spontaneous (12%), sub-optimal ConA-induced 
(18%) and optimal LPS-induced lymphocyte proliferation (12%) while exposure to 10 µM DA 
significantly increased only sub-optimal ConA-induced (18%) and optimal LPS-induced (8%) 
lymphocyte proliferation (Figure 7). Exposure to 100 µM DA, in contrast, significantly decreased 
spontaneous (12%), sub-optimal ConA-induced (12%) and optimal LPS-induced (7%) lymphocyte 
proliferation (Figure 7).   
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Figure 6. In vitro peripheral blood neutrophil (top) and monocyte (bottom) phagocytosis 
(mean +SD) with increasing concentrations of DA (n=10; RM ANOVA, *p < 0.05). 
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Figure 7. In vitro mitogen-induced lymphocyte (splenocyte) proliferation (mean +SD) 
with increasing concentrations of DA (n=10; RM ANOVA, *p < 0.05). 
 
 
2.7 Mobilization of calcium in blood leukocytes 
Mouse mean peripheral blood neutrophil, monocyte and lymphocyte fluorescence increased by 
407%, 408%, and 408%, respectively, 1 min following exposure to ionomycin (data not shown), 
suggesting appropriate cell loading with the probe. The results for calcium mobilization upon exposure 
to increasing concentrations of DA are shown in Figure 8. For all three sub-populations of leukocytes, 
1 µM DA consistently reduced cytosolic calcium, as measured by a reduction of cell fluorescence 
compared to baseline fluorescence. For neutrophils and lymphocytes, 10 µM DA also reduced 
cytosolic calcium, while calcium was moderately increased in monocytes. 100 µM DA moderately 
increased cytosolic calcium in monocytes, while calcium was modestly increased in neutrophils and 
lymphocytes. 
The results for calcium mobilization upon exposure to the different glutamate receptor agonists in 
comparison to DA are shown in Figure 9. For all three sub-populations of leukocytes, DA consistently 
reduced cytosolic calcium, as measured by a reduction in cell fluorescence compared to baseline 
fluorescence. The only agonists that also induced a consistent reduction in cytosolic calcium in 
neutrophils, monocytes, and lymphocytes (Figure 8) were kainate, L-glutamate, and AMPA, 
respectively. However, the magnitude of the change induced by those agonists was consistently less 
than that induced by DA for neutrophils and lymphocytes. 
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Figure 8. Changes in peripheral blood neutrophil (top), monocyte (middle), and 
lymphocyte (bottom) cytosolic calcium upon exposure to increasing concentrations of 
domoic acid. Data are expressed as the % of the unexposed control over time (T-1: 1 min 
prior to exposure, T0: time of exposure to agonists, T2: 2 min after exposure, T4: 4 min 
after exposure, T6: 6 min after exposure). For each time point, data are presented as the 
average of 3 mice. (100% indicated by dotted line) 
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Figure 9. Changes in peripheral blood neutrophil (top), monocyte (middle), and 
lymphocyte (bottom) cytosolic calcium upon exposure to the ionotropic glutamate 
receptor agonists , L-glutamate, kainate, AMPA, NMDA, as well as domoic acid (all at 1 
µM).  Data are expressed as the % of the unexposed control over time (T-1: 1 min prior to 
exposure, T0: time of exposure to agonists, T2: 2 min after exposure, T4: 4 min after 
exposure, T6: 6 min after exposure). For each time point, data are presented as the average 
of 3 mice per agonists. (100% indicated by dotted line) 
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3. Discussion and Conclusion 
To the authors’ knowledge, this is the first report to demonstrate the immunotoxic effects of DA in 
any mammalian species. Previous reports demonstrated that DA was not immunotoxic either upon in 
vitro exposure of isolated human dendritic cells [28] or rats exposed in vivo [29], although different 
cell types and route of exposure were employed. When exposed to physiologically relevant 
concentrations of DA, different responses were observed between in vivo and in vitro exposure. This 
may reflect differences in exposure times, ADME (especially excretion, see below) and the potential 
for both direct and indirect effects of DA on immune cells following in vitro and in vivo exposure.  
3.1 In vivo exposure 
In vivo exposure to DA modulated both innate and adaptive immune cell functions and effects 
appeared to be cell type- and time-specific.  In general, it appeared that in vivo DA exposure acutely 
enhanced innate immune function (monocyte phagocytosis) by 12 hr, followed by immune suppression 
of both innate (neutrophil phagocytosis) and adaptive (T lymphocyte proliferation) immune functions 
by 24 hr, and with return to control levels 48 hr after exposure. This time course correlates well with 
the clearance of DA from mouse blood, with almost 99% clearance by 24 hr [30, 31].   
In a similar study following in vivo DA exposure, gene expression in mouse peripheral blood 
leukocytes was assayed (Ryan, J., personal communication).  Several chemokines were found to be 
differentially expressed, including the down regulation of Ccl5/Rantes, which was also shown to be 
down regulated in monocytes exposed to glucocorticoids in vitro [32]. In addition, DA exposure in 
vivo also produced an up regulation in integrin alpha 4, which was shown to be important in 
recruitment of mononuclear cells to sites of inflammation but also necessary for immune cells to 
permeate the CNS [33]. Interestingly, isolated rat astrocytes exposed to 10 µM DA showed up 
regulation of chemokine genes for IL-1α, IL-1β, IL-6 [34].  The relationships between changes in 
immune cell gene expression and immune functions, which may be related to or independent of 
glucocorticoid and glutamate receptors, warrant future studies. 
3.2 In vitro exposure 
In vitro exposure to DA directly modulated innate and adaptive immune cell functions, although the 
effects were different (direction of change and affected cell types) from in vivo exposure. Neutrophil (1 
and 2 or more beads) and monocyte (1 or more beads) phagocytosis were significantly reduced only at 
the lowest concentration tested. It is possible that the most active phagocytic cells (3+) may not have 
been the preferential targets of DA. Lymphocyte proliferation, including spontaneous as well as T and 
B cell induced, was increased at low concentrations and decreased at high concentrations (further 
discussed below). Hormetic immune responses are not unusual following exposure to various 
endogenous and exogenous chemicals [35, 36]. T cell proliferation was significantly modulated by DA 
using only the sub-optimal concentration of ConA.  In this case, lymphocytes that were proliferating at 
a slower rate proved to be more sensitive to the immunotoxic effects of DA than lymphocytes 
proliferation at a higher rate. Importantly, this effect would have been missed if only using the optimal 
ConA mitogen concentration. This highlights the need to test both suboptimal and optimal 
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concentrations of mitogens when assessing the immunotoxicity of chemicals on lymphocyte 
proliferation [37]. 
3.3 Potential mechanism(s)/pathways(s) mediating in vitro DA-induced immunotoxicty 
Experiments were initiated to determine the mechanisms and pathways by which DA may exert its 
immunotoxic effects. Experiments were performed with limited numbers of mice (n=3) to assess 
qualitative trends in modulation of cytosolic calcium by DA, a well described effect documented in 
various neural and non-neural cells [15], to determine whether the presence of glutamate receptors 
(and their different sub-types) on immune cells may be involved in DA-induced immunotoxicity.  
DA exposure resulted in qualitative reductions and increases in cytosolic calcium compared to 
unexposed control in all three leukocyte subtypes tested in the present study.  Numerous reports have 
documented increases in cytosolic calcium in different cell types (see review by Pulido, 2008). 
Similarly, cytosolic calcium slightly increased in all cell types upon exposure to 100 µM DA, with the 
greatest increase in monocytes. However, upon exposure to 1 µM (for all cell types) and 10 µM (for 
neutrophils and lymphocytes), cytosolic calcium was decreased.  In this case, DA may have induced 
calcium sequestration into the endoplasmic recticulum and/or mitochondria, a response documented by 
glutamate receptor agonist [38-40]. 
For all three immune cell subtypes, changes in cytosolic calcium were compared to changes in 
immune functions (upon in vitro exposure) in an initial attempt to explain DA-induced 
immunotoxicity. For neutrophils and monocytes, phagocytosis was significantly reduced only at 1 µM 
DA, the same concentration that also reduced cytosolic calcium in both cell types. As calcium 
mobilization is necessary for phagocytosis [41, 42], the lack of free cytosolic calcium may help 
explain the reduction in phagocytosis. Although calcium was reduced by 10 µM in both cell types, no 
significant changes in phagocytosis were observed, an observation not easily explained at this time. At 
100 µM, no significant changes in phagocytosis were observed and corresponded with modest to 
moderate increases in calcium in neutrophils and monocytes, respectively, suggesting that these 
increases in calcium were not involved in modulating phagocytosis. 
Limited data exists for glutamate receptors on differentiated monocytes.  U937 cells (human 
histiocytic lymphoma derived) demonstrated differential growth and morphology upon exposure to 
glutamate receptor agonists depending on external glutamate concentrations [25].  In primary rat 
microglial cells [43], kainate induced rapid redistribution of the actin cytoskeleton, a necessary step in 
the process of phagocytosis. NMDA receptors have been identified on rat macrophages [21]. Our 
results also demonstrated a consistent reduction in cytosolic calcium upon stimulation with L-
glutamate receptors in monocytes that was consistent with that for DA (at least 4 and 6 min. post-
exposure), suggesting the presence and functionality of Glutamate-responsive receptors on mouse 
monocytes, and the possibility that they could be involved in mediating the toxicity of DA on those 
cells. Taken together, these data suggest that glutamate receptors exist on monocytes and may be 
involved in modulating phagocytosis. Nevertheless, the presence and potential role of glutamate 
receptors responsive to DA on neutrophils are unknown at this time, and none of the receptor sub-
types matched the direction and magnitude of change in cytosolic calcium obtained with DA. 
For both T and B lymphocyte, 100 µM DA significantly reduced lymphocyte proliferation, which 
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corresponded with a very modest increase in calcium mobilization. Although increases in cytosolic 
calcium have been show to reduce lymphocyte proliferation [44], it is not possible to conclude that this 
was the case in this study. Interestingly, 1 and 10 µM DA significantly increased proliferation, which 
corresponded with reduced cytosolic calcium in peripheral blood lymphocytes. The role of reduced 
calcium in mediating proliferation appears unlikely. Alternatively, modulation of voltage-activated 
potassium channels by glutamate [45] may be one mechanism that explains both enhancement and 
suppression of T lymphocyte proliferation.  Poulopoulou et al. (2005) demonstrated that low glutamate 
concentrations (below 100 µM) positively modulated potassium channel gating resulting in T 
lymphocytes that were readily responsive to stimuli with a maximal effect at 1 µM.  In contrast, 
glutamate at concentrations >100 µM was shown to decrease potassium channel currents thereby 
inhibiting T lymphocyte responsiveness to stimuli. The previous study may help explain how the low 
and medium concentrations of DA enhanced lymphocyte proliferation while high concentrations of 
DA reduced proliferation in the current study. Although no report has demonstrated the effects of 
glutamate on B cells, they may share common mechanisms and pathways with T cells. Taken together, 
these data support that glutamate receptors may be involved in modulation of lymphocyte 
proliferation, but our studies have not identified a receptor sub-type that could match the magnitude of 
cytosolic calcium mobilization induced by DA.   
Though studies have identified glutamate receptor subtypes on human and rodent immune cells [22-
24], clearly, additional work must be performed to confirm that DA can exert its immunomodulatory 
effects through these receptors. 
3.4 Differences between direct vs indirect effects 
There are two possible explanations to account for differences in DA-induced immunotoxicity 
between in vitro and in vivo exposure. First, in vitro exposure was carried out at fixed concentrations 
for the entire incubation period, whereas following in vivo exposure, immune cells would not be 
exposed to prolonged high concentrations due to the rapid renal excretion of DA, which reduces the 
ultimate concentration of DA in blood to which immune cells are exposed. Therefore, the final 
concentration of DA ‘seen’ by immune cells would differ between in vitro and in vivo exposure. 
Second, modulation of immune functions in vivo may be secondary to the direct effects of DA on 
other organ systems. There is clear evidence that the central nervous system modulates the peripheral 
immune system through the hypothalamic-pituitary-adrenal (HPA) axis [46].  It is possible that DA 
binding to glutamate receptors in the hippocampus, the well-described mechanism by which DA exerts 
its neurotoxic effects [47, 48], may activate the HPA axis, resulting in release of adrenocorticotropic 
hormone (ACTH). Microinjection of agonists to hippocampal glutamate receptors, including the 
AMPA subtype receptor which DA can bind, induced elevation of plasma ATCH in a dose-dependent 
fashion [49]. ACTH, in turn, induces adrenal release of glucocorticoids, which modulate innate and 
adaptive immune responses [50-52]. Glucocorticoids exert their effects by binding to the cytosolic 
glucocorticoid receptor (GC), a ligand-dependent transcription factor, which regulates gene expression 
and functions in immune cells. For example, human monocytes exposed in vitro to glucocorticoids 
resulted in an induction of “phagocytic” genes and was associated with an approximate 2.5-fold 
increase in phagocytosis of fluorescent latex beads and complement opsonized Leishmania major, 
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compared to controls [32].  In the present study, monocyte phagocytosis of fluorescent latex beads was 
enhanced at 12 hr. Glucocorticoids were shown to suppress neutrophil phagocytosis [50, 53] and 
suppress lymphocyte proliferation [54, 55], similar to the effects observed in the present study. Gene 
expression changes seen in the brain after DA exposure are consistent with an increase in 
glucocorticoid production with the up-regulation of serum and glucocorticoid kinase, and Gilz 
(glucocorticoid induced leucine zipper) [56]. Further in the same study, several immune relevant genes 
were differentially expressed in the brain such as cyclooxygenase 2, CSA-conditional T cell activation 
dependent protein, and alpha and beta subunits of cytotoxic T lymphocyte-associated protein 2. In the 
current study, glucocorticoid levels were not measured, but should be explored in future experiments 
to help elucidate indirect mechanisms upon in vivo DA exposure.  
Different glutamate receptor types/expression/activity between neutrophils, monocytes, and T 
lymphocytes could help explain why monocytes were acutely sensitive to the effects of DA, while the 
response by neutrophils and T lymphocyte was delayed. Interestingly, no effects were observed for B 
lymphocytes, suggesting differences in surface receptors and/or signaling pathways among immune 
cells. 
3.5. Relevancy of immune modulation 
Any modulation of immune functions, whether in increase or decrease, is of concern. Although the 
magnitudes of the changes in immune functions were sometimes small, these changes could have 
significant biological consequences [57].  Reduction of phagocytosis may lead to decreased pathogen 
clearance, allowing opportunistic pathogens to produce disease [58, 59]. Enhancement of phagocytosis 
could lead to premature release of cytosolic lysosomal content and reactive oxygen species, resulting 
in local inflammation and tissue damage [60].  Non-specific and unregulated increases in lymphocyte 
proliferation may be the initiating step in the transformation of a lymphocyte into a cancer cell [61].  
Interestingly, glutamate receptors antagonists have been shown to be important in the suppression of 
some tumors [62, 63], while DA has been show to increase chromosomal abnormalities in the Caco-2 
cell line [64], suggesting a potential role of DA in tumor formation. In addition, non-specific 
stimulation of lymphocyte proliferation may potentially contribute to autoimmune diseases or anergy, 
an active state of unresponsiveness [61]. A reduction in lymphocyte proliferation may prevent the 
expansion of effector and memory T and B lymphocytes, thus increasing an individual’s susceptibility 
to opportunistic infection or neoplasms [65].  
3.6 Conclusion 
This is the first study to demonstrate the immunomodulatory effects of both in vivo and in vitro 
exposure to DA in a mammalian species. In the risk assessment scheme, DA can be viewed as a 
hazard, requiring additional studies, including elucidating the mechanism(s) of action. The present 
study provides initial data to suggest that calcium mobilization and glutamate sub type cell surface 
receptors as potential mechanisms and pathways involved in the response to toxic levels of domoic 
acid in mammals. In addition, future gene expression profiles may help identify specific biomarkers in 
blood that may lead to a biomonitoring system for subacute exposure in humans and protected marine 
species whose populations are exposed annually to toxic algal blooms. 
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4. Experimental Section 
4.1 In vivo exposure 
Domoic acid (DA; Sigma, St Louis, MO) was re-suspended in sterile phosphate buffered saline 
(PBS) at 0.5 µg/µL.  Adult, 25-28 g ICR female mice (Harlan, Indianapolis, IN) were weighed and 
received an intraperitoneal (i.p.) injection of 2.5 µg/g DA (n=10 mice per exposure period) or vehicle 
control (PBS; n=10 mice per exposure period) with a U-100 Insulin syringe and a 28 gauge needle. 
This dose was chosen as it was previously shown in mice to be symptomatic but sub-lethal (Ryan, 
personal communication) [30, 56], as well as inducing changes in brain gene expression [30]. Mice 
were observed for one hr after dosing for any clinical signs of acute DA toxicity. At the end of each 
exposure period (12, 24 or 48 hr), mice were euthanized by CO2 inhalation. Blood was immediately 
collected via cardiac puncture followed by cervical dislocation to ensure death, and spleen was 
removed and stored in ice cold DMEM until processing (below). The study design and procedures 
were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of 
Connecticut. 
4.2 Phagocytosis 
From individual mouse whole blood samples, erythrocytes were lysed using NH4Cl and the 
leukocytes were re-suspended in Hanks Balanced Salt Solution (HBSS, Gibco BRL, Grand Island, 
NY). Cells were washed twice with HBSS, and their viability was assessed using the exclusion dye 
trypan blue. Leukocytes were adjusted to 2 x 106/ml in HBSS and plated (100 µl per well) in a round 
bottom 96-well plate (Falcon, Becton Dickinson, Lincoln Park, NJ) in triplicate.  One µm-diameter 
fluorescent latex beads (Molecular Probes, Eugene, OR) were added to the cell suspension to obtain a 
ratio of approximately 100 beads/cell, and cells were incubated for one hr at 37°C, under agitation at 
300 rpm using a Thermomixer R (Eppendorf, Hamburg, Germany).  The cell suspension from each 
well was then layered on a cushion of ice cold 3% bovine serum albumin (Sigma, St. Louis, MO) and 
centrifuged at 150g for 8 min at 4°C.  The supernatant containing the free beads was discarded and the 
cells were re-suspended in 200 µl of PBS containing 1% neutral buffered formalin (Decal Corp, 
Tallman, NY). Cells were stored at 4°C until analysis (within 24 hr). The fluorescence of 
approximately 10,000 cells was read with a FACScan (Becton Dickinson, Rutherford, NJ) flow 
cytometer using the CellQuest software (Becton Dickinson Immunocytometry System, San Jose, CA).  
Neutrophils and monocytes were gated electronically according to their relative size (forward scatter; 
FSC) and complexity (side scatter; SCC). The fluorescence of the cells was read at 530 nm (FL-1) on a 
logarithmic scale using the fluorescence of free beads as reference. Cells acquired a fluorescence equal 
to that of the number of beads they ingested. Phagocytosis was evaluated as the proportion of 
neutrophil and monocytes that had phagocytized one or more beads (1+, the proportion of all cells that 
participate in phagocytosis, includes 2+ and 3+), two or more beads (2+, includes 3+) and three or 
more beads (3+, the proportion of cells that are most efficient in phagocytosis), the endpoint of 
phagocytosis routinely reported [66-68]. 
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4.3. Lymphocyte proliferation 
From each individual spleen, a single cell suspension was prepared using two pairs of forceps in 
complete Dulbecco’s modified eagle medium (DMEM, Gibco BRL, Grand Island, NY) supplemented 
with (all from Gibco BRL, Grand Island, NY) 1 mM sodium pyruvate, 100 µM non-essential amino 
acids, 25 mM HEPES, 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin, along 
with 10 % fetal bovine serum (Hyclone, Logan, UT), hereafter referred to as complete DMEM.  
Mononuclear cells were isolated by density gradient centrifugation on Ficoll-Paque plus (Amersham 
Biosciences, Uppsala Sweden) for 35 min at 990 g.  The mononuclear cells were re-suspended in 
complete DMEM, washed once, and enumerated with their viability assessed using the exclusion dye 
trypan blue. Lymphocytes in complete DMEM were plated (1 x 106 cells/ml final concentration, 100 µl 
per well) in triplicate in 96 well flat bottom tissue culture plates (Falcon, Becton Dickinson, Franklin 
Lakes, NJ). Cells were incubated at 37°C with 5% CO2 for a total of 66 hr with the T cell mitogen 
concanavalin A (Con A Sigma, St. Louis, MO) or the B cell mitogen lipopolysaccharide (LPS, Sigma, 
St. Louis, MO, USA). Con A was used at a sub-optimal concentration (0.1 µg/ml), as well as at an 
optimal concentration (1 µg/ml).  LPS was used at a sub-optimal concentration (0.05 µg/ml), as well as 
at an optimal concentration (5 µg/ml). Suboptimal concentrations were used as they proved more 
sensitive in detecting immunotoxicity [37]. Lymphocyte proliferation was evaluated as the 
incorporation of 5-bromo-2’-deoxyuridine (BrdU), a thymidine analogue, added for the last 18 hr of 
incubation, and subsequently detected with a monoclonal antibody and a colorimetric enzymatic 
reaction (Cell Proliferation ELISA BrdU (colorimetric), Roche Diagnostics GmbH, Mannheim 
Germany) as per manufacturer’s instructions using an ELISA plate reader (Multiskan EX  v.1.0) at 690 
nm with a reference wavelength of 450 nm. 
4.4 In vitro exposure 
In a separate experiment, individual blood samples (collected via cardiac puncture) and spleens 
from 10 adult ICR female mice were collected immediately after euthanasia, and processed as above, 
then incubated with domoic acid in vitro.  Leukocytes or lymphocytes from the same individual were 
exposed to DA in vitro at 4 concentrations: 1, 10, and 100 µM DA or vehicle only (0 µM).  The 1 µM 
dose was chosen to simulate the blood concentration of DA found in mice two hr after i.p. injection of 
2 µg/g [31]. The 10 µM dose and 100 µM dose approximate concentrations of DA that blood cells may 
experience at early time points (30 and 10 min, respectively) following i.v. injection of 2 µg/g of DA 
[69], a dose slightly below the in vivo dose employed in the current work. Assays for phagocytosis and 
lymphocyte proliferation were performed as described above.   
4.5 Cytosolic calcium mobilization 
In separate experiments, peripheral blood leukocytes were collected, adjusted to 2 x 106/ml, and 
incubated with the fluorescent Ca2+ probe, Fluo-3/acetoxymethyl (3 mM, Molecular Probes, Eugene, 
OR) in a 0.1% bovine serum albumin (Sigma, St. Louis, MO)/HBSS solution at 37°C for 30 min.  
Cells were centrifuged for 10 min at 150 g, re-suspended in HBSS and further incubated at 37°C for an 
additional 30 min (to ensure cleavage of the acetoxymethyl from the probe by non-specific esterases).  
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Cells were centrifuged for 10 min at 150 g and re-suspended in 1.6 mM CaCl2 (Sigma, St. Louis, MO)-
HBSS at room temperature. 
To ensure proper loading of cells with the probe, the fluorescence of a sub-sample of leukocytes 
was read with a FACScan (Becton Dickinson, Rutherford, NJ) flow cytometer using the CellQuest 
software (Becton Dickinson, Immunocytometry System, San Jose, CA) at 530 nm (FL-1) for 30 sec, 
followed by the addition of 1µM ionomycin (Molecular Probes, Eugene, OR), an ionophore used to 
increase cytosolic calcium concentrations.  The fluorescence was recorded for an additional 3 min.  
The basal fluorescence of leukocytes was read with a FACScan flow cytometer at 530 nm (FL-1) 
for 10 sec.  Cells were exposed to 0, 1, 10, and 100 µM DA.  Cell fluorescence was recorded for 10 sec 
1 min before (baseline fluorescence) and every 2 min (for 6 min) immediately following the addition 
of DA (time 0).  Glutamate receptor agonists, kainate, AMPA, NMDA, and L-glutamate (all from 
Sigma, St. Louis, MO), were tested at 0 and 1µM, the same molar concentration shown to modulate 
phagocytosis upon in vitro exposure (see Results).  It was reasoned that if the pattern of calcium 
mobilization for one or more of the selected agonists was similar to that produced by DA, it could be 
inferred that DA exerts its effects through that particular agonist receptor(s). Cell fluorescence was 
simultaneously recorded for all leukocytes. Neutrophils, monocytes, and lymphocytes were then 
analyzed separately based on electron gates. Data were expressed as the relative fluorescence (% 
unexposed) of exposed cells in time relative to the baseline fluorescence (T-1). Data were collected 
from three mice per agonists. 
4.6 Statistics 
For the in vivo experiment, within each time point (12, 24 or 48 hr), DA-exposed mice were 
compared to unexposed (control) mice using a Student’s t-test and p<0.05 for statistical significance.  
For the in vitro experiment, a repeated measures one-way analysis of variance (RM ANOVA) was 
performed to compare the exposed groups to the unexposed group using p<0.05 for statistical 
significance. All analyses were performed using the SigmaStat 3.5 (Systat, San Jose, CA) software. 
Cytosolic calcium mobilization experiments were performed with limited numbers of mice (n=3) to 
assess qualitative trends in modulation of cytosolic calcium by DA, therefore, no statistical analyses 
were performed. 
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